A phase I, single center, open-label parallel group trial to compare the pharmacokinetics of NOMAC between healthy female adolescents (aged 14-17 years) and healthy female adults (aged 18-50 years) after single dose administration of NOMAC-E2 tablets.
Phase of Trial: Phase I
Latest Information Update: 10 Sep 2015
At a glance
- Drugs Estradiol/nomegestrol (Primary)
- Indications Pregnancy
- Focus Pharmacokinetics
- 10 Sep 2015 Results (PK model ) published in the Contraception.
- 05 Jul 2011 New trial record